2013 - Member of Academia Europaea
2001 - Fellow of the Royal Society of Edinburgh
Internal medicine, Cancer, Epidemiology, Case-control study and Risk factor are his primary areas of study. Peter Boyle specializes in Internal medicine, namely Breast cancer. His Cancer research includes themes of Surgery, Lung cancer, Incidence and Environmental health.
His Epidemiology research focuses on Public health and how it connects with Gerontology. His work deals with themes such as Odds ratio, Pancreatic cancer, Relative risk, Confidence interval and Immunology, which intersect with Case-control study. His work deals with themes such as Carcinoma and Pathology, which intersect with Oncology.
Peter Boyle mainly focuses on Internal medicine, Cancer, Epidemiology, Oncology and Breast cancer. His Internal medicine research includes elements of Gastroenterology and Endocrinology. His research integrates issues of Mortality rate, Surgery, Intensive care medicine, Disease and Lung cancer in his study of Cancer.
In his study, which falls under the umbrella issue of Epidemiology, Cohort study is strongly linked to Incidence. In his research, International Prostate Symptom Score is intimately related to Gynecology, which falls under the overarching field of Breast cancer. The various areas that he examines in his Case-control study study include Odds ratio, Physiology and Risk factor.
His main research concerns Internal medicine, Oncology, Cancer, Breast cancer and Diabetes mellitus. The study incorporates disciplines such as Body mass index, Prostate, Pancreatic cancer, Case-control study and Immunology in addition to Oncology. His Cancer research incorporates themes from Lung cancer, Surgery and Incidence.
The Breast cancer study combines topics in areas such as Endocrinology, Insulin, Insulin glargine, Increased risk and Prospective cohort study. His study looks at the relationship between Relative risk and topics such as Gynecology, which overlap with Cancer screening and Mass screening. Peter Boyle regularly links together related areas like Epidemiology in his Meta-analysis studies.
Peter Boyle mostly deals with Internal medicine, Oncology, Breast cancer, Meta-analysis and Cancer. His study in Internal medicine is interdisciplinary in nature, drawing from both Gynecology and Immunology. His Breast cancer research incorporates elements of Endocrinology, Hyperinsulinemia, Public health, Developing country and Disease burden.
His Meta-analysis study combines topics from a wide range of disciplines, such as Diabetes mellitus, Epidemiology, Increased risk and Fasting glucose. His research in Cancer intersects with topics in Lung cancer, Years of potential life lost, Medical research and Bioinformatics. His Publication bias research is multidisciplinary, incorporating elements of Randomized controlled trial and Surgery.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Estimates of the cancer incidence and mortality in Europe in 2006
J Ferlay;P Autier;M Boniol;M Heanue.
Annals of Oncology (2006)
Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review
Aimee R. Kreimer;Gary M. Clifford;Peter Boyle;Silvia Franceschi.
Cancer Epidemiology, Biomarkers & Prevention (2005)
Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7).
Raymond Rosen;Jens Altwein;Peter Boyle;Roger S Kirby.
European Urology (2003)
Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure.
Sara Gandini;Francesco Sera;Maria Sofia Cattaruzza;Paolo Pasquini.
European Journal of Cancer (2005)
Overview of the main outcomes in breast-cancer prevention trials.
J Cuzick;T Powles;U Veronesi;J Forbes.
The Lancet (2003)
Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women
U Veronesi;P Maisonneuve;A Costa;V Sacchini.
The Lancet (1998)
Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study
James V Parle;Patrick Maisonneuve;Michael C Sheppard;Peter Boyle.
The Lancet (2001)
Cancer in patients on dialysis for end-stage renal disease: an international collaborative study.
Patrick Maisonneuve;Lawrence Agodoa;Ryszard Gellert;John H Stewart.
The Lancet (1999)
Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi
Sara Gandini;Francesco Sera;Maria Sofia Cattaruzza;Paolo Pasquini.
European Journal of Cancer (2005)
Tobacco smoking and cancer: A meta-analysis
Sara Gandini;Edoardo Botteri;Simona Iodice;Mathieu Boniol.
International Journal of Cancer (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Strathclyde
European Institute of Oncology
Yale University
Yale University
University of Milan
Mario Negri Institute for Pharmacological Research
University of Paris-Saclay
Centro di Riferimento Oncologico
National Institutes of Health
European Institute of Oncology
Utrecht University
Nanyang Technological University
Nanyang Technological University
Indian Institute of Technology Kanpur
National Institute of Oceanography and Applied Geophysics
Complutense University of Madrid
Kansas State University
North Carolina Wildlife Resources Commission
University of Liverpool
University of Tübingen
University of California, Berkeley
University of Adelaide
Aalborg University
Southeastern Louisiana University
City Of Hope National Medical Center
London School of Economics and Political Science